Attached files
| file | filename |
|---|---|
| EX-3.10.I - CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES E 0% - Inspyr Therapeutics, Inc. | f10k2019ex3-10i_inspyr.htm |
| EX-10.25 - FORM OF SECURITIES PURCHASE AGREEMENT FOR MAY 2020 PREFERRED STOCK OFFERING - Inspyr Therapeutics, Inc. | f10k2019ex10-25_inspyr.htm |
| 10-K - ANNUAL REPORT - Inspyr Therapeutics, Inc. | f10k2019_inspyrthera.htm |
| EX-32.2 - CERTIFICATION - Inspyr Therapeutics, Inc. | f10k2019ex32-2_inspyr.htm |
| EX-32.1 - CERTIFICATION - Inspyr Therapeutics, Inc. | f10k2019ex32-1_inspyr.htm |
| EX-31.2 - CERTIFICATION - Inspyr Therapeutics, Inc. | f10k2019ex31-2_inspyr.htm |
| EX-31.1 - CERTIFICATION - Inspyr Therapeutics, Inc. | f10k2019ex31-1_inspyr.htm |
| EX-4.36 - FORM OF SERIES E PREFERRED STOCK CERTIFICATE - Inspyr Therapeutics, Inc. | f10k2019ex4-36_inspyr.htm |
Exhibit 23.01
CONSENT OF INDEPENDENT REGISTERED CERTIFICATED PUBLIC ACCOUNTANTS
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (SEC File No. 333-192553) of Inspyr Therapeutics, Inc. of our report which includes an explanatory paragraph expressing substantial doubt regarding the Company’s ability to continue as a going concern dated May 14, 2020, relating to our audit of the financial statements which appear in this Annual Report on Form 10-K of Inspyr Therapeutics, Inc. for the year ended December 31, 2019 and 2018.
/s/ Liggett & Webb, P.A.
May 14, 2020
New York, New York